Xeroderma Pigmentosum, Complementation Group C; Xpc

Description

Xeroderma pigmentosum is a genetically heterogeneous condition characterized by increased sensitivity to ultraviolet (UV) irradiation and increased risk of skin cancer resulting from a defect in DNA repair. XPC is the most common form of XP in the white population, accounting for over a third of all cases in this group (review by Li et al., 1993).For a general discussion of xeroderma pigmentosum, see XPA (OMIM ).

Clinical Features

Top most frequent phenotypes and symptoms related to Xeroderma Pigmentosum, Complementation Group C; Xpc

  • Neoplasm
  • Hyperactivity
  • Photophobia
  • Carcinoma
  • Abnormality of the nervous system
  • Hypopigmentation of the skin
  • Cutaneous photosensitivity
  • Telangiectasia
  • Conjunctivitis
  • Neoplasm of the skin

And another 13 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Xeroderma Pigmentosum, Complementation Group C; Xpc Is also known as xp, group c, xp3, xpcc, xeroderma pigmentosum iii.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Xeroderma Pigmentosum, Complementation Group C; Xpc Recommended genes panels

Panel Name, Specifity and genes Tested/covered
XPC. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).

XPC
Specificity
100 %
Genes
100 %
Xeroderma pigmentosum disease (sequence analysis of XPC gene).

By CGC Genetics (Portugal).

XPC
Specificity
100 %
Genes
100 %
OncoRisk Plus (NGS panel for 89 genes).

By CGC Genetics (Portugal).

RUNX1, BLM, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, SMARCB1, STK11, BUB1B, EPCAM, TP53, TSC1, TSC2, VHL, WRN, WT1, XPA, XPC , (...)

View the complete list with 68 more genes
Specificity
2 %
Genes
100 %
Xeroderma Pigmentosum via XPC Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics (United States).

XPC
Specificity
100 %
Genes
100 %
Xeroderma Pigmentosum Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics (United States).

XPA, XPC, DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH
Specificity
12 %
Genes
100 %
Xeroderma pigmentosum Comprehensive panel.

By Connective Tissue Gene Tests (United States).

XPA, XPC, DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH
Specificity
12 %
Genes
100 %
Xeroderma pigmentosum NGS panel.

By Connective Tissue Gene Tests (United States).

XPA, XPC, DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH
Specificity
12 %
Genes
100 %
Xeroderma pigmentosum Deletion / Duplication panel.

By Connective Tissue Gene Tests (United States).

XPA, XPC, DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH
Specificity
12 %
Genes
100 %

You can get up to 31 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM MESH Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PANCREATITIS, HEREDITARY; PCTT GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD ALSTROM SYNDROME; ALMS FAMILIAL PAPILLARY OR FOLLICULAR THYROID CARCINOMA MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET; EMARDD MUENKE SYNDROME; MNKES CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E